Fred Hutch, Seattle Cancer Care Alliance, and UW Medicine Complete Restructure of Partnership
Learn More
close
Fred Hutch - Cures Start Here®
Research
Pioneering Scientific Research
Research Areas
Behavioral Research
Biostatistics
Cell & Gene Therapy
Cell Biology
Data Science
Diagnostics & Biomarkers
Disease Prevention
Epidemiology
Gene Regulation & Expression
Genetics & Genomics
Global Health
Health Economics
Hematopoietic Transplantation
Immunotherapy
Infectious Diseases
Microbiome
Survivorship
Vaccine Development
Virology
Diseases
Autoimmune Diseases
Cancers
COVID-19
Genetic Disorders
Herpes
HIV/AIDS
Divisions
Basic Sciences Division
Clinical Research Division
Human Biology Division
Public Health Sciences Division
Vaccine and Infectious Disease Division
Clinical Trials & Studies
Clinical Trials FAQ
Patient Treatment & Support
Meet Our Clinicians
Make an Appointment
Patient Stories
Long-Term Follow-Up
Survivorship Program
Cook for Your Life
Faculty & Lab Directory
COVID-19 Clinical Research Center
Office of Education & Training
Institutes, Networks & IRCs
Projects & Studies
Scientific Publications
Shared Resources
Investors & Industry
Collaborating for Cures
Business Development
Available Technologies
Collaborations & Spinoffs
Commercialization
Events & Conferences
Team
News
Driving Innovation
Shared Facilities
GMP Manufacturing
Team Science
Data-Intensive Bioscience
Contact Us
About Us
Cures Start Here
About The Hutch
Accountability & Impact
Diversity, Equity & Inclusion
Facilities & Infrastructure
History
Honors & Awards
Institutional Partners & Collaborations
Leadership
Mission & Values
Contact Us
Campus Map
Virtual Campus Visit
Scientific Staff Directory
Global Locations
Careers
Internships
Science Education Outreach (SciEd)
Events and Seminars
For the Media
Ways to Give
Why Your Gift Matters
Give Now
Honor a Loved One
Give Through Your Will
Give Through Your Donor Advised Fund
Donate Cryptocurrency
Give Through Your Foundation
Make a Corporate Gift
Create an Endowment
Fundraise for Fred Hutch
Obliteride
Climb to Fight Cancer
Create Your Own
Log In to Your Fundraiser
Attend an Event
Support Our Science
Greatest Need and Impact
Cancer Research
COVID-19 Research
Immunotherapy, Data Science, and the Steam Plant
Diversity, Equity and Reduction of Health Disparities
Join a Gift Club
Other Ways to Give
Give Monthly
Donate Stock
Give at Work
Donate Your Vehicle
Contact Philanthropy
Careers
News
Contact
Submit
Donate
Now
Submit
Research
Pioneering Scientific Research
Research Areas
Research Areas
Behavioral Research
Biostatistics
Cell & Gene Therapy
Cell Biology
Data Science
Diagnostics & Biomarkers
Disease Prevention
Epidemiology
Gene Regulation & Expression
Genetics & Genomics
Global Health
Health Economics
Hematopoietic Transplantation
Immunotherapy
Infectious Diseases
Microbiome
Survivorship
Vaccine Development
Virology
Diseases
Diseases
Autoimmune Diseases
Cancers
COVID-19
Genetic Disorders
Herpes
HIV/AIDS
Divisions
Divisions
Basic Sciences Division
Clinical Research Division
Human Biology Division
Public Health Sciences Division
Vaccine and Infectious Disease Division
Clinical Trials & Studies
Clinical Trials & Studies
Clinical Trials FAQ
Patient Treatment & Support
Patient Treatment & Support
Meet Our Clinicians
Make an Appointment
Patient Stories
Long-Term Follow-Up
Survivorship Program
Cook for Your Life
Faculty & Lab Directory
COVID-19 Clinical Research Center
Office of Education & Training
Institutes, Networks & IRCs
Projects & Studies
Scientific Publications
Shared Resources
Investors & Industry
Collaborating for Cures
Business Development
Business Development
Available Technologies
Collaborations & Spinoffs
Commercialization
Events & Conferences
Team
News
Driving Innovation
Driving Innovation
Shared Facilities
GMP Manufacturing
Team Science
Data-Intensive Bioscience
Contact Us
About Us
Cures Start Here
About The Hutch
About The Hutch
Accountability & Impact
Diversity, Equity & Inclusion
Facilities & Infrastructure
History
Honors & Awards
Institutional Partners & Collaborations
Leadership
Mission & Values
Contact Us
Contact Us
Campus Map
Virtual Campus Visit
Scientific Staff Directory
Global Locations
Careers
Internships
Science Education Outreach (SciEd)
Events and Seminars
For the Media
Ways to Give
Why Your Gift Matters
Give Now
Honor a Loved One
Give Through Your Will
Give Through Your Donor Advised Fund
Donate Cryptocurrency
Give Through Your Foundation
Make a Corporate Gift
Create an Endowment
Fundraise for Fred Hutch
Fundraise for Fred Hutch
Obliteride
Climb to Fight Cancer
Create Your Own
Log In to Your Fundraiser
Attend an Event
Support Our Science
Support Our Science
Greatest Need and Impact
Cancer Research
COVID-19 Research
Immunotherapy, Data Science, and the Steam Plant
Diversity, Equity and Reduction of Health Disparities
Join a Gift Club
Other Ways to Give
Other Ways to Give
Give Monthly
Donate Stock
Give at Work
Donate Your Vehicle
Contact Philanthropy
Careers
News
Contact
Donate Now
Hutch News
Science Spotlight
News Releases
Scientific Publications
For the Media
Media Coverage
Stories tagged pembrolizumab
Results per Page:
20
5
10
20
50
100
How RNA-altering drugs might improve anticancer immunotherapies
In lab study, brief disruptions of gene machinery make tumor cells more 'visible' to immune system
Hutch News - June 24, 2021
Tags
basic sciences
Robert Bradley
immunotherapy development
checkpoint inhibitors
RNA
alternative rna splicing
pembrolizumab
Herbold Computational Biology Program
Cancer Neo-antigen
COVID-19
Basic Sciences
Public Health Sciences
Herbold Computational Biology Program
Share
Breaking down HIV exclusions in cancer clinical trials
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life
Hutch News - June 07, 2019
Tags
HIV-AIDS
pembrolizumab
Lung Cancer
Thomas Uldrick
Martin Cheever
Clinical Research
clinical trials
national cancer institutes
kaposi
cancer immunotherapy trials network
Liver Cancer
non-hodgkin lymphoma
anal cancer
squamous cell carcinoma
Transplant and Immunotherapy
ASCO 2019
ASCO
scientific conferences
Share
On immunotherapy trial, long-term survivors of deadly skin cancer point to a hopeful future
Once unheard-of survival rates seen among patients with advanced Merkel cell carcinoma
Hutch News - February 06, 2019
Tags
immunotherapy
Transplant and Immunotherapy
merkel cell carcinoma
pembrolizumab
Clinical Research
cancer immunotherapy trials network
Martin Cheever
Paul Nghiem
Share
Immunotherapy has long-term benefit for patients with advanced Merkel cell carcinoma
‘Incredibly big change’ in treatment of deadly skin cancer, new data show
Hutch News - June 04, 2018
Tags
Paul Nghiem
Clinical Research
immunotherapy
Transplant and Immunotherapy
checkpoint inhibitors
pembrolizumab
merkel cell carcinoma
skin cancer
ASCO 2018
pathogen-associated malignancies
Share
For cancer patients with HIV, immunotherapy appears safe
Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials
Hutch News - November 07, 2017
Tags
cancer immunotherapy trials network
hiv
pembrolizumab
checkpoint inhibitors
hiv aids
kaposi
Sarcoma
Pathogen-Associated Malignancies IRC
immunotherapy
immunotherapy research
clinical trials
infection-related cancers
Vaccine and Infectious Disease Division (VIDD)
global oncology
Thomas Uldrick
ASCO 2019
ASCO
scientific conferences
Share
The tumor microenvironment: How cancer fools healthy neighboring cells
‘Tumor microenvironment’ research underscores why we need cancer immunotherapy — and how to make it work for more patients
Hutch News - July 18, 2017
Tags
Clinical Research
immunotherapy
Lung Cancer
Ovarian Cancer
McGarry Houghton
Philip D Greenberg
Robert Pierce
T cell
t cell therapy
checkpoint inhibitors
pembrolizumab
solid tumors
Transplant and Immunotherapy
Share
A new blood test detects recurrence of rare skin cancer
$200 assay can accurately signal return of Merkel cell carcinoma — in some cases catching tumors earlier than expensive imaging
Hutch News - December 12, 2016
Tags
merkel cell carcinoma
Clinical Research
Human Biology
Paul Nghiem
Denise Galloway
virus
immunotherapy
pembrolizumab
cancer recurrence
Molecular basis of cancer
Share
Scratching the surface of a rare skin cancer
Immune-boosting therapy shows promise for advanced Merkel cell carcinoma
Hutch News - October 06, 2015
Tags
Paul Nghiem
pembrolizumab
Martin Cheever
David Koelle
SCCA
cancer immunotherapy trials network
immunotherapy
merkel cell carcinoma
skin cancer
T cell
Share
Fred Hutchinson Cancer Center
Hutch News
Last Modified, April 02, 2020